Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review. | Pharmaceuticals (Basel) | 2023 | 37259456 | PubTator, text mining | PubMed |
| Targeting breast cancer stem cells directly to treat refractory breast cancer. | Front Oncol | 2023 | 37251931 | PubTator, text mining | PubMed |
| Prognostic Value and Immunological Role of P4HA3 in Colon Adenocarcinoma. | Int J Gen Med | 2023 | 37251280 | PubTator, text mining | PubMed |
| Target Discovery Using Deep Learning-Based Molecular Docking and Predicted Protein Structures With AlphaFold for Novel Antipsychotics. | Psychiatry Investig | 2023 | 37248690 | PubTator, text mining | PubMed |
| CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies. | Diagnostics (Basel) | 2023 | 37238199 | PubTator, text mining | PubMed |
| Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it? | J Med Virol | 2023 | 37212317 | PubTator, text mining | PubMed |
| Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response. | BMC Complement Med Ther | 2023 | 37202806 | PubTator, text mining | PubMed |
| Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy. | Mol Ther Nucleic Acids | 2023 | 37200859 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker. | Aging (Albany NY) | 2023 | 37199628 | PubTator, text mining | PubMed |
| Regulatory T cells in peripheral tissue tolerance and diseases. | Front Immunol | 2023 | 37197653 | PubTator, text mining | PubMed |
| A new prognostic model for RHOV, ABCC2, and CYP4B1 to predict the prognosis and association with immune infiltration of lung adenocarcinoma. | J Thorac Dis | 2023 | 37197482 | PubTator, text mining | PubMed |
| An overview of extrahepatic cholangiocarcinoma: from here to where? | Front Oncol | 2023 | 37197436 | PubTator, text mining | PubMed |
| The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. | Biomedicines | 2023 | 37189677 | PubTator, text mining | PubMed |
| Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing. | Front Immunol | 2023 | 37187731 | PubTator, text mining | PubMed |
| Antibody-based cancer immunotherapy by targeting regulatory T cells. | Front Oncol | 2023 | 37182149 | PubTator, text mining | PubMed |
| Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs. | Front Pharmacol | 2023 | 37180708 | PubTator, text mining | PubMed |
| Implication of allergy and atopy in IgG4-related disease. | World Allergy Organ J | 2023 | 37179536 | PubTator, text mining | PubMed |
| From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID. | Int J Mol Sci | 2023 | 37175995 | PubTator, text mining | PubMed |
| Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma. | BMC Bioinformatics | 2023 | 37170221 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis. | medRxiv | 2023 | 37163015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=15